07:00 , Jul 4, 2011 |  BC Week In Review  |  Clinical News

Accurun 644 Control regulatory update

SeraCare received CE Mark approval for its Accurun 644 Control cystic fibrosis (CF) diagnostic. The test, which identifies mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene, will be available in Europe immediately...